A Seamless Phase II/III, Observer-blind, to Evaluate Immunogenicity and Safety of Chikungunya Virus Vaccine in Healthy Subjects 12-65Years of Age.
Clinical trial NCT07555392 · RECRUITING
Trial details
- NCT number
- NCT07555392
- Sponsor
- Bharat Biotech International Limited
- Status
- RECRUITING
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2026-04-20
- Primary completion
- 2026-09-20
- Enrollment
- 1000
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.